Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988-1994

Sexually Transmitted Diseases

Volumn 35, Issue 5, 2008, Pages 472-479

  Staras, Stephanie A S ^a,b,c   Flanders, W Dana ^b   Dollard, Sheila C ^c   Pass, Robert F ^d   McGowan Jr , John E ^b   Cannon, Michael J ^b,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CAUCASIAN; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ETHNICITY; FEMALE; HERPES SIMPLEX; HIGH RISK POPULATION; HISPANIC; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; RACE; SEROPREVALENCE; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; STANDARD; UNITED STATES; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIGENS, VIRAL; CHILD; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, HORIZONTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; NUTRITION SURVEYS; PREVENTIVE HEALTH SERVICES; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; UNITED STATES;

EID: 43449097538     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e3181644b70     Document Type: Article

References (42)

1. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 17:253-276.
2. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007; 17:355-363.
3. Centers for Disease Control and Prevention. Ten great public health achievements, 1990-1999: Impact of vaccines universally recommended for children. MMWR Morb Mortal Wkly Rep 1999; 48:241-243.
4. Pass RF, Burke RL. Development of cytomegalovirus vaccines: Prospects for prevention of congenital CMV infection. Semin Pediatr Infect Dis 2002; 13:196-204.
5. Kimberlin DW, Lin CY, Sanchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: A randomized, controlled trial. J Pediatr 2003; 143:16-25.
6. Yow MD, Demmler GJ. Congenital cytomegalovirus disease - 20 years is long enough. N Engl J Med 1992; 326:702-703.
7. Griffiths PD. Strategies to prevent CMV infection in the neonate. Semin Neonatol 2002; 7:293-299.
8. Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Public Health 2005; 5:70.
9. American College of Obstetricians and Gynecologists (ACOG). Perinatal Viral and Parasitic Infections. Washington, DC: American College of Obstetricians and Gynecologists (ACOG), September 13, 2000 (ACOG practice bulletin; no. 20). Available at: http://www.medem.com/search/article_display. cfm?path=%5C% 5CTANQUERAY&mstr=/M_ContentItem/ZZZA2QESIEC.html&soc= ACOG&srch_typ=NAV_SERCH. Accessed November 30, 2007.
10. Fisher S, Genbacev O, Maidji E, et al. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: Implications for transmission and pathogenesis. J Virol 2000; 74:6808-6820.
11. Reynolds DW, Stagno S, Hosty TS, et al. Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med 1973; 289:1-5.
12. Hamprecht K, Maschmann J, Vochem M, et al. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 2001; 357:513-518.
13. Peckham CS, Johnson C, Ades A, et al. Early acquisition of cytomegalovirus infection. Arch Dis Child 1987; 62:780-785.
14. Adler S. Molecular epidemiology of cytomegalovirus: Viral transmission among children attending a day care center, their parents, and caregivers. J Pediatr 1988; 112:366-372.
15. Fowler KB, Pass RF. Risk factors for congenital cytomegalovirus infection in the offspring of young women: Exposure to young children and recent onset of sexual activity. Pediatrics 2006; 118:e286-e292.
16. Staras SAS, Dollard SC, Radford KW, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006; 43:1143-1151.
17. Sohn YM, Oh MK, Balcarek KB, et al. Cytomegalovirus infection in sexually active adolescents. J Infect Dis 1991; 163:460-463.
18. Collier AC, Handsfield HH, Roberts PL, et al. Cytomegalovirus infection in women attending a sexually transmitted disease clinic. J Infect Dis 1990; 162:46-51.
19. Deleted in proof.
20. Colugnati FA, Staras SA, Dollard SC, et al. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect Dis 2007; 7:71.
21. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutrition Examination Survey, 1988-1994. Hyattsville, MD: National Center for Health Statistics, 1994. Available at: http://www.cdc.gov/ nchs/data/series/sr_01/sr01_032.pdf. Accessed November 30, 2007.
22. Centers for Disease Control and Prevention. Analytic and Reporting Guidelines: The Third National Health and Nutrition Examination Survey, NHANES III (1988-1994). Hyattsville, MD: National Center for Health Statistics, 1996. Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf. Accessed November 30, 2007.
23. Halpern CT, Hallfors D, Bauer DJ, et al. Implications of racial and gender differences in patterns of adolescent risk behavior for HIV and other sexually transmitted diseases. Perspect Sex Reprod Health 2004; 36:239-247.
24. Cubbins LA, Tanfer K. The influence of gender on sex: A study of men's and women's self-reported high-risk sex behavior. Arch Sex Behav 2000; 29:229-257.
25. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997; 337:1105-1111.
26. Deleted in proof.
27. Research Triangle Institute. SUDAAN Language Manual, Release 9.0. Research Triangle Park, NC: Research Triangle Institute, 2004.
28. Mohadjer L, Montaquila J, Waksberg J. National Health and Nutrition Examination Survey III: Weighting and Examination Methodology. Hyattsville, MD: National Center for Health Statistics, 1996. Available at: http://www.cdc.gov/ nchs/data/nhanes/nhanes3/cdrom/NCHS/MANUALS/WGT_EXEC.PDF. Accessed November 30, 2007.
29. Lane PW, Nelder JA. Analysis of covariance and standardization as instances of prediction. Biometrics 1982; 38:613-621.
30. Flanders WD, Rhodes PH. Large sample confidence intervals for regression standardized risks, risk ratios, and risk differences. J Chronic Dis 1987; 40:697-704.
31. Miller WC, Ford CA, Morris M, et al. Prevalence of chlamydial and gonococcal infections among young adults in the United States. JAMA 2004; 291:2229-2236.
32. Ellen JM, Brown BA, Chung SE, et al. Impact of sexual networks on risk for gonorrhea and chlamydia among low-income urban African American adolescents. J Pediatr 2005; 146:518-522.
33. Laumann EO, Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: A network explanation. Sex Transm Dis 1999; 26:250-261.
34. Witkin SS, Linhares IM, Giraldo P. Bacterial flora of the female genital tract: Function and immune regulation. Best Pract Res Clin Obstet Gynaecol 2007; 21:347-354.
35. Stevens-Simon C, Jamison J, McGregor JA, et al. Racial variation in vaginal pH among healthy sexually active adolescents. Sex Transm Dis 1994; 21:168-172.
36. Joint United Nations Programme on HIV/AIDS. Women and AIDS. Geneva, Switzerland: UNAIDS Best Practice Collection: Point of View, October, 1997. Available at: http://data.unaids.org/Publications/IRC-pub04/Women-PoV_en.pdf. Accessed November 30, 2007.
37. Auerswald CL, Muth SQ, Brown B, et al. Does partner selection contribute to sex differences in sexually transmitted infection rates among African American adolescents in San Francisco? Sex Transm Dis 2006; 33:480-484.
38. Mertz GJ, Benedetti J, Ashley R, et al. Risk factors for the sexual transmission of genital herpes. Ann Intern Med 1992; 116:197-202.
39. Drew WL, Blair M, Miner RC, et al. Evaluation of the virus permeability of a new condom for women. Sex Transm Dis 1990; 17:110-112.
40. Robain M, Carre N, Dussaix E, et al. Incidence and sexual risk factors of cytomegalovirus seroconversion in HIV-infected subjects. The SEROCO study group. Sex Transm Dis 1998; 25:476-480.
41. Katznelson S, Drew WL, Mintz L. Efficacy of the condom as a barrier to the transmission of cytomegalovirus. J Infect Dis 1984; 150:155-157.
42. Jeon J, Victor M, Adler SP, et al. Knowledge and awareness of congenital cytomegalovirus among women. Infect Dis Obstet Gynecol 2006; 2006:80383.